The Rutgers University Translational Addiction Research Program (RU-TARP), a component of the Rutgers Brain Health Institute (BHI), has multiple positions available for postdoctoral fellows to study aspects of substance use disorders. Levels of analysis include both basic (drug self-administration coupled with calcium imaging, molecular biology, epigenetics, DREADDs, optogenetics, etc.) and clinical (functional imaging, epidemiology, clinical trials, etc.) lines of investigation. NIH-funded investigators include Drs. Gary Aston-Jones, David Barker, Tammy Chung, Samantha Farris, Perry Halkitis, Daniel Langleben, Morgan James, Teresa Leyro, Zhiping Pang, Chris Pierce, John Pintar, Mark Rossi, Dipak Sarkar, Marc Steinberg, Stanley Weiss and Mark West. Rutgers University has supported cutting-edge research on the causes and consequences of various substance use disorders for decades with a strong record of post-doctoral mentorship and training. The commitment to addiction research continues with development of a new Rutgers Addiction Research Center which includes targeted faculty hiring in this area and a framework for the training of pre- and post-doctoral fellows through seminars, journal clubs, work-in-progress meetings and individualized training plans. With over 250 neuroscience faculty labs engaged in basic, clinical and translational research, and proximity to New York, Princeton and Philadelphia neuroscience communities, Rutgers offers tremendous training and career growth opportunities. Those interested in joining this dynamic research community are encouraged to contact Dr. Chris Pierce ([email protected]), Associate Director of BHI for Education and Training.
Rutgers, The State University of New Jersey, is an Equal Opportunity/Affirmative Action Employer. Qualified applicants will be considered for employment without regard to race, creed, color, religion, sex, sexual orientation, gender identity or expression, national origin, disability status, genetic information, protected veteran status, military service or any other category protected by law. As an institution, we value diversity of background and opinion, and prohibit discrimination or harassment on the basis of any legally protected class in the areas of hiring, recruitment, promotion, transfer, demotion, training, compensation, pay fringe benefits, layoff, termination or any other terms and conditions of employment
About Rutgers University
New Jersey’s academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health. Aligned with Rutgers University–New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and six centers and institutes that focus on cancer treatment and research, neuroscience, clinical and translational research, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research. Our faculty are teachers, clinicians, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings. We offer an outstanding education in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers. Our clinical and academic facilities are located throughout the state including New Brunswick, Piscataway, Newark, Scotch Plains, Somerset, Blackwood, and other locations. Clinical partners include Robert Wood Johnson University Hospital in New Brunswick, University Hospital in Newark, and other affiliates.